Literature DB >> 31954112

Could a Blood Marker of T-Cell Exhaustion be Inflammatory Bowel Disease's New Crystal Ball?

Zoë S Gottlieb1, Ryan Ungaro1.   

Abstract

Entities:  

Year:  2020        PMID： 31954112      PMCID： PMC7062560          DOI： 10.1053/j.gastro.2020.01.021

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  13 in total

1.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.

Authors:  C A Siegel; H Horton; L S Siegel; K D Thompson; T Mackenzie; S K Stewart; P W Rice; J M Stempak; S Dezfoli; T Haritunians; A Levy; M Baek; R Milgrom; P S Dulai; S R Targan; M S Silverberg; M C Dubinsky; D P McGovern
Journal:  Aliment Pharmacol Ther       Date:  2015-11-15       Impact factor: 8.171

Review 3.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

4.  Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.

Authors:  Takayuki Yamamoto; Manabu Shiraki; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  Int J Colorectal Dis       Date:  2013-12-17       Impact factor: 2.571

Review 5.  Clinical Utility of Biomarkers in IBD.

Authors:  Gerhard Rogler; Luc Biedermann
Journal:  Curr Gastroenterol Rep       Date:  2015-07

6.  Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Authors:  Subra Kugathasan; Lee A Denson; Thomas D Walters; Mi-Ok Kim; Urko M Marigorta; Melanie Schirmer; Kajari Mondal; Chunyan Liu; Anne Griffiths; Joshua D Noe; Wallace V Crandall; Scott Snapper; Shervin Rabizadeh; Joel R Rosh; Jason M Shapiro; Stephen Guthery; David R Mack; Richard Kellermayer; Michael D Kappelman; Steven Steiner; Dedrick E Moulton; David Keljo; Stanley Cohen; Maria Oliva-Hemker; Melvin B Heyman; Anthony R Otley; Susan S Baker; Jonathan S Evans; Barbara S Kirschner; Ashish S Patel; David Ziring; Bruce C Trapnell; Francisco A Sylvester; Michael C Stephens; Robert N Baldassano; James F Markowitz; Judy Cho; Ramnik J Xavier; Curtis Huttenhower; Bruce J Aronow; Greg Gibson; Jeffrey S Hyams; Marla C Dubinsky
Journal:  Lancet       Date:  2017-03-02       Impact factor: 79.321

7.  Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

Authors:  Takayuki Yamamoto; Manabu Shiraki; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

8.  PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.

Authors:  Miles Parkes; Nurulamin M Noor; Francis Dowling; Harvey Leung; Simon Bond; Lynne Whitehead; Sara Upponi; Paul Kinnon; Andrew P Sandham; Paul A Lyons; Eoin F McKinney; Kenneth G C Smith; James C Lee
Journal:  BMJ Open       Date:  2018-12-05       Impact factor: 2.692

9.  A blood-based prognostic biomarker in IBD.

Authors:  Daniele Biasci; James C Lee; Nurulamin M Noor; Diana R Pombal; Monica Hou; Nina Lewis; Tariq Ahmad; Ailsa Hart; Miles Parkes; Eoin F McKinney; Paul A Lyons; Kenneth G C Smith
Journal:  Gut       Date:  2019-04-27       Impact factor: 23.059

10.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Authors:  Isabelle Cleynen; Gabrielle Boucher; Luke Jostins; L Philip Schumm; Sebastian Zeissig; Tariq Ahmad; Vibeke Andersen; Jane M Andrews; Vito Annese; Stephan Brand; Steven R Brant; Judy H Cho; Mark J Daly; Marla Dubinsky; Richard H Duerr; Lynnette R Ferguson; Andre Franke; Richard B Gearry; Philippe Goyette; Hakon Hakonarson; Jonas Halfvarson; Johannes R Hov; Hailang Huang; Nicholas A Kennedy; Limas Kupcinskas; Ian C Lawrance; James C Lee; Jack Satsangi; Stephan Schreiber; Emilie Théâtre; Andrea E van der Meulen-de Jong; Rinse K Weersma; David C Wilson; Miles Parkes; Severine Vermeire; John D Rioux; John Mansfield; Mark S Silverberg; Graham Radford-Smith; Dermot P B McGovern; Jeffrey C Barrett; Charlie W Lees
Journal:  Lancet       Date:  2015-10-18       Impact factor: 202.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.